Adrianne C. Feldstein, MD, MS
Articles by Adrianne C. Feldstein, MD, MS

More Comprehensive Discussion of CRC Screening Associated With Higher Screening
ByDavid M. Mosen, PhD, MPH,Adrianne C. Feldstein, MD, MS,Nancy A. Perrin, PhD,A. Gabriela Rosales, MS,David H. Smith, RPh, PhD,Elizabeth G. Liles, MD,Jennifer L. Schneider, MPH,Ronald E. Myers, PhD,Jennifer Elston Lafata, PhD More comprehensive discussion of colorectal screening by primary care physicians was associated with higher screening rates among adults aged 51 to 80 years who were overdue for screening.

Automated Telephone Calls to Enhance Colorectal Cancer Screening: Economic Analysis
ByDavid H. Smith, RPh, PhD,Adrianne C. Feldstein, MD, MS,Nancy Perrin, PhD,A. Gabriela Rosales, MS,David M. Mosen, PhD, MPH,Elizabeth G. Liles, MD,Jennifer L. Schneider, MPH,Jennifer E. Lafata, PhD,Ronald E. Myers, PhD,Russell E. Glasgow, PhD Automated telephone calls can increase colorectal cancer screening rates at a cost of about $40 per additional screen.

Change to FIT Increased CRC Screening Rates: Evaluation of a US Screening Outreach Program
ByElizabeth G. Liles, MD, MSCR,Nancy Perrin, PhD,Ana Gabriela Rosales, MS,Adrianne C. Feldstein, MD, MS,David H. Smith, RPh, MHA, PhD,David M. Mosen, PhD, MPH,Jennifer L. Schneider, MPH Fecal immunochemical testing resulted in higher colorectal cancer screening rates than did guaiac fecal occult blood tests, with less dependence on office visits.

Effect of a Patient Panel-Support Tool on Care Delivery
ByAdrianne C. Feldstein, MD, MS,Nancy A. Perrin, PhD,Robert Unitan, MD,A. Gabriela Rosales, MS,Gregory A. Nichols, PhD,David H. Smith, RPh, MHA, PhD,Jennifer Schneider, MPH,Carrie M. Davino, MD A panel-support tool in a managed care setting improved the percentage of care recommendations met for patients with diabetes mellitus or cardiovascular disease.